- Report
- February 2024
- 250 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Drug Pipelines
- October 2020
- 62 Pages
Global
From €3364EUR$3,500USD£2,885GBP
- Report
- October 2023
- 72 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- June 2023
- 88 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- April 2023
- 77 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- January 2021
- 140 Pages
China, Global
From €3000EUR$3,344USD£2,663GBP
- Drug Pipelines
- October 2020
- 53 Pages
Global
From €3364EUR$3,500USD£2,885GBP
- Drug Pipelines
- August 2019
- 32 Pages
Global
From €3364EUR$3,500USD£2,885GBP
- Report
- March 2022
- 116 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Book
- September 2023
- 808 Pages
Collagenase is an enzyme that breaks down collagen, a major component of connective tissue. It is used in a variety of medical and industrial applications, including tissue engineering, wound healing, and bioprocessing. Collagenase is also used in the production of cosmetics, food, and pharmaceuticals.
Collagenase is produced by a variety of organisms, including bacteria, fungi, and plants. It is available in a range of forms, including powder, liquid, and tablets. The enzyme is also available in a variety of concentrations, depending on the application.
The collagenase market is highly competitive, with a number of companies offering products for a variety of applications. Companies in the market include Sigma-Aldrich, Merck KGaA, Roche, Novozymes, and Enzyme Solutions. Show Less Read more
